ousia's update: half year results, page-23

I would really welcome an informed view from Biota on how Relenza interacts with the Influenza virus and whether resistance is likely to be more likely, less likely or the same as other anti virals such as Tamiflu.
says Khaliter
This is the main point in this whole BTA/GSK saga. We and also the Press are talking so much of Relenza quality and its comparison with Tamiflu. But no word from Biota. Does the contractual agreement with GSK refrain Biota advertising and pointing out quality of their product with comparison to Tamiflu? Because of the court case GSK is down ramping Relenza; why Biota cannot up ramping Relenza and create public image alert. By keeping quiet Biota is the looser imho.
Biota's latest financial report keeps sh in dark.